Sinotherapeutics, Inc. Class ASSE: 688247

Announcement on Implementation of Dividend Distribution for 2025

Jun 22, 2026 · Issued by Sinotherapeutics, Inc. Class A via Shanghai Stock Exchange

Announcement on Implementation of Dividend Distribution for 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Earlier from Sinotherapeutics, Inc. Class A

Announcement on the Expiry of Planned Time for Shareholders with Over 5% Shares to Reduce Shares and Results of Shareholding ReductionJun 11
Senior Management Member" -- Announcement on Completing Term Change and Election of the Board of Directors and Appointing Senior Management Members and Securities Affairs Representative, as well as Departure of Core Technical PersonnelMay 29
Announcement on Voluntary Disclosure of Obtaining the Colombian INVIMA Approval for Bupropion Hydrochloride Extended-release TabletsMay 26
Notice on Convening the 2025 Annual General MeetingApr 30

All Sinotherapeutics, Inc. Class A news releases